Carlos Sanchez Priego

Field Application Scientist @ MaxWell Biosystems

About

Expert in neuroscience, genetics, epigenetics and cell engineering. Proven track record in leading genetic studies and mentoring other scientists in the areas of NGS and CRISPR technologies. Passionate about incorporating cutting edge technologies into biological research that lead to new therapeutic areas. Skill: • In vitro cell culture • Cell reprogramming • Cell differentiation • Neuronal cultures • MEA • Calcium imaging • Flow Cytometry • Microscopy • CRISPR design • Cell line generation • Genetic engineering • Proliferation and apoptosis assays • Lentiviral and retroviral infections • DNA and RNA extraction • NGS technologies • Molecular cloning • Multiomics • shRNA and siRNA • RNA-seq • MS/MS • SILAC • ChIP-seq • ATAC-seq • Plasmid and primer design • Protein extraction • Western Blot (WB) • Co-immunoprecipitation (Co-IP) • Immunofluorescence (IF)

Country

United States

City

San Mateo

Industry

Biotechnology

Skill

Networking, Leadership, Research, Biotechnology, Problem Solving, Teamwork, Supervisory Skills, Interpersonal Skills, Training & Development, Debate, Public Speaking, Biomedical Sciences, Training, Stem Cells, RNA, Philosophy, Chromatin, In Vitro

Experience

Field Application Scientist

MaxWell Biosystems

2025-9 - Present · 1 yr 1 mo

Senior Scientist - Spatial Transcriptomics

Alector

2024-7 - 2025-3 · 9 mos

San Francisco Bay Area

- Catalyzed design and execution of all transcriptomic projects across Biology and Target Discovery teams, focusing on neurodegenerative disorders. - Forged new partnerships with CROs, directing all inter-company collaborations in transcriptomics and epigenomics. - Engineered and executed library preparations and QC for multi-omics, CITE-seq, single-cell RNA-seq, and spatial transcriptomics projects. - Orchestrated collaborations with the Stem Cell group to develop SOPs and readouts for pipeline projects and target discovery initiatives.-

Scientist 3 - Neuro Stem Cell Group

Genentech

2022-2 - 2024-6 · 2 yrs 5 mos

- Drove genetic and proteomic studies focused on neurodegenerative diseases, propelling a compound from early research to near clinical trials in just 2 years. - Pioneered new genetic tools using CRISPR technology for the entire Neuroscience department. - Mobilized multiple scientists in developing novel neurodegeneration models using stem cells. - Executed comprehensive characterization of cellular models through single-cell RNA-seq, multi-omics, and proteomics (10x Genomics platforms). - Optimized quality control of stem cell-derived brain cell types using FACS, RT-PCR, and high-resolution imaging. - Equipped scientists, postdocs, and contractors with expertise in stem cell technologies, neuronal differentiation protocols and next-generation sequencing techniques.